Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurobiol Dis

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    April 2019
  1. CHOI DJ, An J, Jou I, Park SM, et al
    A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression.
    Neurobiol Dis. 2019;127:482-491.
    PubMed     Text format     Abstract available


    March 2019
  2. LOFREDI R, Tan H, Neumann WJ, Yeh CH, et al
    Beta bursts during continuous movements accompany the velocity decrement in Parkinson's disease patients.
    Neurobiol Dis. 2019 Mar 18. pii: S0969-9961(19)30068.
    PubMed     Text format     Abstract available


  3. SAMPSON T
    The impact of indigenous microbes on Parkinson's disease.
    Neurobiol Dis. 2019 Mar 15. pii: S0969-9961(19)30069.
    PubMed     Text format     Abstract available


    February 2019
  4. SHAHID M, Kim J, Leaver K, Hendershott T, et al
    An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Ass42 and an APOE epsilon4 allele.
    Neurobiol Dis. 2019 Feb 28. pii: S0969-9961(18)30655.
    PubMed     Text format     Abstract available


  5. KIRKLEY KS, Popichak KA, Hammond SL, Davies C, et al
    Genetic suppression of IKK2/NF-kappaB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease.
    Neurobiol Dis. 2019 Feb 25. pii: S0969-9961(19)30050.
    PubMed     Text format     Abstract available


  6. SABIR MS, Blauwendraat C, Ahmed S, Serrano GE, et al
    Assessment of APOE in atypical parkinsonism syndromes.
    Neurobiol Dis. 2019 Feb 21. pii: S0969-9961(19)30046.
    PubMed     Text format     Abstract available


  7. MEIDAHL AC, Moll CKE, van Wijk B, Gulberti A, et al
    Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Neurobiol Dis. 2019 Feb 9. pii: S0969-9961(19)30037.
    PubMed     Text format     Abstract available


    January 2019
  8. BADEN P, Yu C, Deleidi M
    Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems.
    Neurobiol Dis. 2019 Jan 31. pii: S0969-9961(19)30032.
    PubMed     Text format     Abstract available


  9. GLAAB E, Trezzi JP, Greuel A, Jager C, et al
    Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease.
    Neurobiol Dis. 2019 Jan 9. pii: S0969-9961(19)30002.
    PubMed     Text format     Abstract available


    December 2018
  10. DODIYA HB, Forsyth CB, Voigt RM, Engen PA, et al
    Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Dec 20. pii: S0969-9961(18)30768.
    PubMed     Text format     Abstract available


  11. MUS L, Siani F, Giuliano C, Ghezzi C, et al
    Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity.
    Neurobiol Dis. 2018 Dec 3. pii: S0969-9961(18)30756.
    PubMed     Text format     Abstract available


    November 2018
  12. HUANG YR, Xie XX, Ji M, Yu XL, et al
    Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Nov 24. pii: S0969-9961(18)30401.
    PubMed     Text format     Abstract available


  13. CHO SS, Christopher L, Koshimori Y, Li C, et al
    Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway.
    Neurobiol Dis. 2018;124:176-182.
    PubMed     Text format     Abstract available


  14. REED X, Bandres-Ciga S, Blauwendraat C, Cookson MR, et al
    The role of monogenic genes in idiopathic Parkinson's disease.
    Neurobiol Dis. 2018 Nov 15. pii: S0969-9961(18)30668.
    PubMed     Text format     Abstract available


  15. IKEDA-MATSUO Y, Miyata H, Mizoguchi T, Ohama E, et al
    Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Neurobiol Dis. 2018 Nov 10. pii: S0969-9961(18)30741.
    PubMed     Text format     Abstract available


  16. SAMPEDRO F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, et al
    Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
    Neurobiol Dis. 2018 Nov 5. pii: S0969-9961(18)30544.
    PubMed     Text format     Abstract available


  17. LAMONTAGNE-PROULX J, St-Amour I, Labib R, Pilon J, et al
    Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.
    Neurobiol Dis. 2018 Nov 5. pii: S0969-9961(18)30534.
    PubMed     Text format     Abstract available


  18. MILOSEVIC L, Gramer R, Kim TH, Algarni M, et al
    Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Neurobiol Dis. 2018 Nov 1. pii: S0969-9961(18)30593.
    PubMed     Text format     Abstract available


    October 2018
  19. WEIHOFEN A, Liu Y, Arndt JW, Huy C, et al
    Development of an aggregate-selective, human-derived alpha-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.
    Neurobiol Dis. 2018 Oct 28. pii: S0969-9961(18)30448.
    PubMed     Text format     Abstract available


  20. HERNANDO S, Requejo C, Herran E, Ruiz-Ortega JA, et al
    Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
    Neurobiol Dis. 2018 Oct 5. pii: S0969-9961(18)30292.
    PubMed     Text format     Abstract available


    September 2018
  21. SOYAL SM, Zara G, Ferger B, Felder TK, et al
    The PPARGC1A locus and CNS-specific PGC-1alpha isoforms are associated with Parkinson's Disease.
    Neurobiol Dis. 2018 Sep 17. pii: S0969-9961(18)30591.
    PubMed     Text format     Abstract available


  22. PINA-FUENTES D, van Zijl JC, van Dijk JMC, Little S, et al
    The characteristics of pallidal low-frequency and beta bursts could help implementing adaptive brain stimulation in the parkinsonian and dystonic internal globus pallidus.
    Neurobiol Dis. 2018 Sep 15. pii: S0969-9961(18)30391.
    PubMed     Text format     Abstract available


  23. MAMMADOVA N, Summers CM, Kokemuller RD, He Q, et al
    Accelerated accumulation of retinal alpha-synuclein (pSer129) and tau, neuroinflammation and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Sep 12. pii: S0969-9961(18)30204.
    PubMed     Text format     Abstract available


  24. ANIDI CM, O'Day JJ, Anderson RW, Afzal MF, et al
    Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Neurobiol Dis. 2018 Sep 6. pii: S0969-9961(18)30548.
    PubMed     Text format     Abstract available


    August 2018
  25. TUBERT C, Galtieri D, James Surmeier D
    The pedunclopontine nucleus and Parkinson's disease.
    Neurobiol Dis. 2018 Aug 29. pii: S0969-9961(18)30493.
    PubMed     Text format     Abstract available


  26. MOLONEY EB, Moskites A, Ferrari EJ, Isacson O, et al
    The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress.
    Neurobiol Dis. 2018 Aug 24. pii: S0969-9961(18)30484.
    PubMed     Text format     Abstract available


  27. GOETZ L, Piallat B, Bhattacharjee M, Mathieu H, et al
    Spike discharge characteristic of the caudal mesencephalic reticular formation and pedunculopontine nucleus in MPTP-induced primate model of Parkinson disease.
    Neurobiol Dis. 2018 Aug 4. pii: S0969-9961(18)30394.
    PubMed     Text format     Abstract available


    June 2018
  28. THEVATHASAN W, Moro E
    What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?
    Neurobiol Dis. 2018 Jun 19. pii: S0969-9961(18)30193.
    PubMed     Text format     Abstract available


  29. TINKHAUSER G, Torrecillos F, Duclos Y, Tan H, et al
    Beta burst coupling across the motor circuit in Parkinson's disease.
    Neurobiol Dis. 2018 Jun 14. pii: S0969-9961(18)30182.
    PubMed     Text format     Abstract available


  30. TOZZI A, Durante V, Bastioli G, Mazzocchetti P, et al
    Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
    Neurobiol Dis. 2018 Jun 13. pii: S0969-9961(18)30185.
    PubMed     Text format     Abstract available


    May 2018
  31. POLAR CA, Gupta R, Lehmkuhle MJ, Dorval AD, et al
    Correlation between cortical beta power and gait speed is suppressed in a parkinsonian model, but restored by therapeutic deep brain stimulation.
    Neurobiol Dis. 2018 May 30. pii: S0969-9961(18)30151.
    PubMed     Text format     Abstract available


    April 2018
  32. PAN PY, Zhu Y, Shen Y, Yue Z, et al
    Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease.
    Neurobiol Dis. 2018 Apr 30. pii: S0969-9961(18)30136.
    PubMed     Text format     Abstract available


  33. WANG H, Atik A, Stewart T, Ginghina C, et al
    Plasma alpha-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study.
    Neurobiol Dis. 2018 Apr 26. pii: S0969-9961(18)30123.
    PubMed     Text format     Abstract available


  34. ANDERSEN MA, Christensen KV, Badolo L, Smith GP, et al
    Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-alpha-synuclein is normalized by LRRK2 modulation.
    Neurobiol Dis. 2018 Apr 19. pii: S0969-9961(18)30119.
    PubMed     Text format     Abstract available


  35. DE MIRANDA BR, Rocha EM, Bai Q, El Ayadi A, et al
    Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    Neurobiol Dis. 2018 Apr 9. pii: S0969-9961(18)30116.
    PubMed     Text format     Abstract available


    March 2018
  36. GLEAVE JA, Arathoon LR, Trinh D, Lizal KE, et al
    Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146].
    Neurobiol Dis. 2018 Mar 20. pii: S0969-9961(18)30054.
    PubMed     Text format    


  37. PITCAIRN C, Wani WY, Mazzulli JR
    Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.
    Neurobiol Dis. 2018 Mar 14. pii: S0969-9961(18)30074.
    PubMed     Text format     Abstract available


  38. PUSKA G, Lutz MI, Molnar K, Regelsberger G, et al
    Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Neurobiol Dis. 2018 Mar 2. pii: S0969-9961(18)30061.
    PubMed     Text format     Abstract available


    February 2018
  39. RIZZI N, Brunialti E, Cerri S, Cermisoni G, et al
    In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30037.
    PubMed     Text format     Abstract available


  40. PIERCE SE, Tyson T, Booms A, Prahl J, et al
    Parkinson's disease genetic risk in a midbrain neuronal cell line.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30039.
    PubMed     Text format     Abstract available


  41. WU HM, Li T, Wang ZF, Huang SS, et al
    Mitochondrial DNA variants modulate genetic susceptibility to Parkinson's disease in Han Chinese.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30047.
    PubMed     Text format     Abstract available


    January 2018
  42. ALCALAY RN, Wolf P, Levy OA, Kang UJ, et al
    Alpha galactosidase A activity in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 21. pii: S0969-9961(18)30018.
    PubMed     Text format     Abstract available


  43. MERCADO G, Castillo V, Soto P, Lopez N, et al
    Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.
    Neurobiol Dis. 2018 Jan 17. pii: S0969-9961(18)30004.
    PubMed     Text format     Abstract available


  44. SHAROTT A, Gulberti A, Hamel W, Koppen JA, et al
    Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 4. pii: S0969-9961(18)30001.
    PubMed     Text format     Abstract available


  45. ALDRIN-KIRK P, Heuer A, Rylander Ottosson D, Davidsson M, et al
    Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Neurobiol Dis. 2018;109.
    PubMed     Text format     Abstract available


    December 2017
  46. NELSON MP, Boutin M, Tse TE, Lu H, et al
    The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.
    Neurobiol Dis. 2017;110:68-81.
    PubMed     Text format     Abstract available


    October 2017
  47. SPIGOLON G, Cavaccini A, Trusel M, Tonini R, et al
    cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.
    Neurobiol Dis. 2017 Oct 28. pii: S0969-9961(17)30243.
    PubMed     Text format     Abstract available


    September 2017
  48. SYRKIN-NIKOLAU J, Koop MM, Prieto T, Anidi C, et al
    Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease.
    Neurobiol Dis. 2017 Sep 7. pii: S0969-9961(17)30214.
    PubMed     Text format     Abstract available


    August 2017
  49. BIOSA A, Sandrelli F, Beltramini M, Greggio E, et al
    Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.
    Neurobiol Dis. 2017 Aug 17. pii: S0969-9961(17)30186.
    PubMed     Text format     Abstract available


    July 2017
  50. RYDBIRK R, Elfving B, Andersen MD, Langbol MA, et al
    Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
    Neurobiol Dis. 2017;106:269-278.
    PubMed     Text format     Abstract available


    June 2017
  51. ARATHOON LR, Gleave JA, Trinh D, Lizal KE, et al
    Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism.
    Neurobiol Dis. 2017 Jun 30. pii: S0969-9961(17)30136.
    PubMed     Text format     Abstract available


    May 2017
  52. GIESERT F, Glasl L, Zimprich A, Ernst L, et al
    The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
    Neurobiol Dis. 2017 May 30. pii: S0969-9961(17)30123.
    PubMed     Text format     Abstract available


    April 2017
  53. JULIENNE H, Buhl E, Leslie DS, Hodge JJL, et al
    Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
    Neurobiol Dis. 2017 Apr 20. pii: S0969-9961(17)30088.
    PubMed     Text format     Abstract available


  54. CAVALIERE F, Cerf L, Dehay B, Ramos-Gonzalez P, et al
    In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
    Neurobiol Dis. 2017;103:101-112.
    PubMed     Text format     Abstract available


  55. ROCHA EM, De Miranda B, Sanders LH
    Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Neurobiol Dis. 2017 Apr 8. pii: S0969-9961(17)30080.
    PubMed     Text format     Abstract available


    March 2017
  56. LALOUX C, Gouel F, Lachaud C, Timmerman K, et al
    Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
    Neurobiol Dis. 2017 Mar 28. pii: S0969-9961(17)30061.
    PubMed     Text format     Abstract available


    December 2016
  57. SONG L, McMackin M, Nguyen A, Cortopassi G, et al
    Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30314.
    PubMed     Text format     Abstract available


  58. MASILAMONI GJ, Groover O, Smith Y
    Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30315.
    PubMed     Text format     Abstract available


  59. VAINE CA, Shin D, Liu C, Hendriks W, et al
    X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Neurobiol Dis. 2016 Dec 22. pii: S0969-9961(16)30299.
    PubMed     Text format     Abstract available


  60. GENG X, Zhang J, Jiang Y, Ashkan K, et al
    Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.
    Neurobiol Dis. 2016;98:100-107.
    PubMed     Text format     Abstract available


  61. KOZINA EA, Kim AR, Kurina AY, Ugrumov MV, et al
    Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Neurobiol Dis. 2016;98:108-121.
    PubMed     Text format     Abstract available


    September 2016
  62. NKILIZA A, Mutez E, Simonin C, Lepretre F, et al
    RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Neurobiol Dis. 2016 Sep 20. pii: S0969-9961(16)30230.
    PubMed     Text format     Abstract available


  63. KIRIK D, Cederfjall E, Halliday G, Petersen A, et al
    Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands.
    Neurobiol Dis. 2016 Sep 8. pii: S0969-9961(16)30222.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: